Relationship: Interstitial Cystitis & Vulvodynia-Part 2

Status Completed

Clinical Trial Summary

The etiology of pain in women with IC is often difficult to identify resulting in unnecessary medical and surgical treatments (e.g. hysterectomies). The vulva may actually be the site of some of the reported pain in women with IC, not the urethra or bladder. IC and vulvodynia can impact one's sexual functioning and diminish one's quality of life. Unfortunately, vulvodynia is often unrecognized since it is not part of the usual urological assessment with IC patients.

Vulvodynia is characterized by persistent generalized or localized vulvar pain of varying degrees often characterized as "burning," suggestive of a neuropathic pain response.

Clinical Trial Description

In a mailed survey (Part 1 of this study), 127 women with a documented diagnosis of IC agreed to be contacted for an in-office examination. The mailed survey was internally developed specifically for this project and included items related to demographics, adolescent and adult history related to genital pain and current health. The last section allowed the subject to include contact information if they would also like to participate in Part 2 (additional questionnaires and examination) of the study.

The study coordinator will review those surveys containing contact information and all women at least 18 years of age will be invited to the WISH program (Beaumont Women's Initiative for Pelvic Pain and Sexual Health) to be examined by a certified Nurse Practitioner (NP) who will be blinded to their survey responses.

Questionnaires will be completed by the subject. These questionnaires relate to one's history, pain symptoms, quality of life, bladder symptoms and sexual function and will be completed prior to the examination. The NP will perform all the clinical evaluations. A vaginal pH and wet mount slide will be done first. Testing for vulvodynia will be done utilizing an algesiometer q-tip followed by Neurometer® surface CPT testing for pain threshold (not tolerance) to quantify pain levels in the distribution of the pudendal nerve on the perineum and vulva will be done. The Neurometer® current perception threshold (CPT) is a device for evaluating and measuring sensation It is a battery-operated stimulator which delivers painless electrical stimulation via surface electrodes at frequencies of 5 Hz, 250 Hz, and 2000 Hz and at a current of 0.01 to 99mAmps. ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00751010
Study type	Observational
Source	William Beaumont Hospitals
Contact
Status	Completed
Phase	N/A
Start date	September 2008
Completion date	September 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05478746` - Effects of Flourish HEC on Localized Provoked Vulvodynia	N/A
Completed	`NCT02404961` - Women's Health Study: Immunological Factors and Risk of Vulvodynia
Completed	`NCT00607490` - A Randomized Clinical Trial for Women With Vulvodynia	N/A
Recruiting	`NCT03640624` - Multidisciplinary Treatment of Chronic Vulvar Pain	N/A
Recruiting	`NCT05343182` - Vestibulectomy Surgical Techniques Comparison Study	N/A
Recruiting	`NCT05518630` - An Investigation of Nomothetic Versus Idiographic Assessment in Chronic Pain
Recruiting	`NCT05597358` - Efficacy of High Intensity Laser for Provoked Vestibulodynia	N/A
Completed	`NCT01304589` - Savella in Treatment for Provoked Vestibulodynia	Phase 3
Completed	`NCT00590590` - Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort	Phase 2
Recruiting	`NCT06138171` - Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Completed	`NCT01996384` - Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study	Phase 1
Completed	`NCT01664962` - Search for Genetic Basis of Vulvodynia	N/A
Recruiting	`NCT05955313` - Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia	Phase 2
Completed	`NCT02773641` - Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia	Phase 3
Completed	`NCT00501774` - A Search for Helicobacter Pylori in Localized Vulvodynia	N/A
Completed	`NCT04057755` - Botulinum Toxin A as a Treatment for Provoked Vestibulodynia	Phase 3
Recruiting	`NCT04016467` - Effect of Spinal Manipulation on Vulvar Pain	N/A
Completed	`NCT01935063` - Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia	N/A
Completed	`NCT02809612` - An Internet-based Information Platform for Vulvodynia Patients	N/A
Not yet recruiting	`NCT02393911` - Dysbiosis in Localized Provoked Vulvodynia (LPV)	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.